Axonics devices are implanted to help control incontinence and can last as long as 17 to 24 years or more Raymond Cohen says he knew the moment when Axonics Inc., which he co-founded in 2013, would ...
Medical Device Network on MSN
Sacral neuromodulation: broadening Boston Scientific’s European urology portfolio
Boston Scientific added SNM to its urology portfolio following its 2024 acquisition of Axonics.
Medical device giant Boston Scientific announced a $3.7 billion deal on Monday to augment its urology portfolio. The company is acquiring Axonics, a maker of neurostimulation devices that treat ...
Based in Irvine, device maker Axonics Inc. reported fourth-quarter revenue climbed 61% to $85.6 million to $86 million, topping the $78.1 million expected by analysts. “This quarter’s record revenue ...
Medical device maker Boston Scientific said on Monday it had agreed to buy Axonics for $3.7 billion, gaining access to devices used to improve bladder function. The deal marks Boston Scientific's ...
IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc., the developer of the first rechargeable Sacral Neuromodulation (r-SNM™) System for the treatment of urinary and fecal ...
Axonics, Inc. AXNX has received regulatory approval from the Therapeutic Goods Administration (TGA) to market its R20 rechargeable sacral neuromodulation (SNM) system in Australia. This cutting-edge ...
Sept 19 (Reuters) - Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's (MDT.N), opens new tab patent rights in nerve-stimulation ...
Jan 8 (Reuters) - Medical device maker Boston Scientific (BSX.N), opens new tab said on Monday it had agreed to buy Axonics Inc (AXNX.O), opens new tab for $3.7 billion, gaining access to devices used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results